Editorial: Molecular targets for anticancer drug discovery and development

Monde Ntwasa; Zodwa Dlamini

doi:10.3389/fgene.2024.1374867

Editorial: Molecular targets for anticancer drug discovery and development

Front Genet. 2024 Apr 3:15:1374867. doi: 10.3389/fgene.2024.1374867. eCollection 2024.

Authors

Monde Ntwasa¹, Zodwa Dlamini²

Affiliations

¹ Department of Life and Consumer Sciences, University of South Africa, Florida, South Africa.
² SAMRC Precision Oncology Research Unit (PORU), DSI/NRF SARChI Chair in Precision Oncology and Cancer Prevention (POCP), University of Pretoria, Pretoria, South Africa.

No abstract available

Keywords: drug repurposing; model organisms (Drosophila); molecularly targeted therapies; pharmacogenetics; pharmacogenomics; small molecule anticancer drugs.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was funded by the South African Medical Research Council (SAMRC), grant number 23108 and the National Research Foundation (NRF), grant number 138139.